BlackRock’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $834K | Buy |
416,889
+551
| +0.1% | +$1.1K | ﹤0.01% | 4240 |
|
|
2025
Q1 | $1.04M | Buy |
416,338
+4,785
| +1% | +$12K | ﹤0.01% | 4129 |
|
|
2024
Q4 | $1.21M | Sell |
411,553
-576
| -0.1% | -$1.7K | ﹤0.01% | 4128 |
|
|
2024
Q3 | $1.24M | Buy |
412,129
+9,382
| +2% | +$28.2K | ﹤0.01% | 4081 |
|
|
2024
Q2 | $1.4M | Buy |
402,747
+54,309
| +16% | +$189K | ﹤0.01% | 4027 |
|
|
2024
Q1 | $1.84M | Buy |
348,438
+1,755
| +0.5% | +$9.27K | ﹤0.01% | 3969 |
|
|
2023
Q4 | $1.78M | Buy |
346,683
+258,637
| +294% | +$1.33M | ﹤0.01% | 4007 |
|
|
2023
Q3 | $461K | Sell |
88,046
-16,960
| -16% | -$88.9K | ﹤0.01% | 4381 |
|
|
2023
Q2 | $196K | Sell |
105,006
-335,076
| -76% | -$627K | ﹤0.01% | 4658 |
|
|
2023
Q1 | $1.65M | Buy |
440,082
+31,150
| +8% | +$117K | ﹤0.01% | 4056 |
|
|
2022
Q4 | $1.26M | Buy |
408,932
+19,113
| +5% | +$59.1K | ﹤0.01% | 4255 |
|
|
2022
Q3 | $1.78M | Sell |
389,819
-716
| -0.2% | -$3.27K | ﹤0.01% | 4160 |
|
|
2022
Q2 | $10.3M | Sell |
390,535
-546
| -0.1% | -$14.4K | ﹤0.01% | 3420 |
|
|
2022
Q1 | $14.5M | Sell |
391,081
-5,392
| -1% | -$201K | ﹤0.01% | 3297 |
|
|
2021
Q4 | $23.2M | Buy |
396,473
+4,857
| +1% | +$284K | ﹤0.01% | 3125 |
|
|
2021
Q3 | $32.2M | Buy |
391,616
+3,282
| +0.8% | +$270K | ﹤0.01% | 2917 |
|
|
2021
Q2 | $36.7M | Buy |
388,334
+299,881
| +339% | +$28.3M | ﹤0.01% | 2856 |
|
|
2021
Q1 | $5.65M | Buy |
88,453
+87,312
| +7,652% | +$5.58M | ﹤0.01% | 3826 |
|
|
2020
Q4 | $66K | Buy |
1,141
+43
| +4% | +$2.49K | ﹤0.01% | 4560 |
|
|
2020
Q3 | $23K | Hold |
1,098
| – | – | ﹤0.01% | 4600 |
|
|
2020
Q2 | $17K | Sell |
1,098
-51
| -4% | -$790 | ﹤0.01% | 4638 |
|
|
2020
Q1 | $15K | Buy |
1,149
+95
| +9% | +$1.24K | ﹤0.01% | 4586 |
|
|
2019
Q4 | $22K | Buy |
+1,054
| New | +$22K | ﹤0.01% | 4581 |
|